feed,title,long_url,short_url
MedRxiv,A Phase III Randomized Controlled Trial Assessing the Safety and Immunogenicity of Biological E's XBB 1.5 RBD Subunit COVID-19 Booster Vaccine in Individuals Aged 5 to 80 Years,https://medrxiv.org/cgi/content/short/2025.06.16.25329675v1?rss=1,
